RSS icon


Up-to-date news about GlySure. For enquiries about any of the stories below, please contact us on +44 (1235) 462 870.
For the latest articles, see below.

Glucose monitoring and the economy

MD&DI 21 August 2012 0:00

MD&DI LogoGlySure CEO Christopher Jones took part in a Q&A with Medical Device & Diagnostic Industry contributing writer John Conroy during which Jones discussed the company's ICU pilot trial results, U.S. and European regulatory approval paths, go to market strategy, and venture capital funding.

Click here to read the full story